88100 Federal Register / Vol. 88, No. 243 / Wednesday, December 20, 2023 / Notices 

the period of performance of an award/ 

project. 

Mandatory Disclosure Requirements 

As required by 2 CFR part 200 of the 

Uniform Guidance, and HHS 

implementing regulations at 45 CFR part 

75, the IHS must require an NFE or an 

applicant for a Federal award to 

disclose, in a timely manner, in writing 

to the IHS or pass-through entity all 

violations of Federal criminal law 

involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 

All applicants and recipients must 

disclose in writing, in a timely manner, 

to the IHS and to the HHS Office of 

Inspector General all information 

related to violations of Federal criminal 

law involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 45 CFR 75.113. 

Disclosures must be sent in writing to: 

U.S. Department of Health and Human 

Services, Indian Health Service, 

Division of Grants Management, 

ATTN: Marsha Brookins, Director, 

5600 Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857 (Include 

‘‘Mandatory Grant Disclosures’’ in 

subject line), Office: (301) 443–5204, 

Fax: (301) 594–0899, Email: DGM@

ihs.gov. 

AND 

U.S. Department of Health and Human 

Services, Office of Inspector General, 

ATTN: Mandatory Grant Disclosures, 

Intake Coordinator, 330 Independence 

Avenue SW, Cohen Building, Room 

5527, Washington, DC 20201, URL: 

https://oig.hhs.gov/fraud/reportfraud/ (Include ‘‘Mandatory Grant 

Disclosures’’ in subject line), Fax: 

(202) 205–0604 (Include ‘‘Mandatory 

Grant Disclosures’’ in subject line) or 

Email: MandatoryGrantee

Disclosures@oig.hhs.gov 

Failure to make required disclosures 

can result in any of the remedies 

described in 45 CFR 75.371 Remedies 

for noncompliance, including 

suspension or debarment (see 2 CFR 

part 180 and 2 CFR part 376). 

VII. Agency Contacts 

1. Questions on the program matters 

may be directed to: Roxanne Houston, 

Program Officer, Indian Health Service, 

Office of Tribal Self-Governance, 5600 

Fishers Lane, Mail Stop: 08E09B, 

Rockville, MD 20857, Phone: (301) 443– 

7821, Email: Roxanne.Houston@ihs.gov, 

website: https://www.ihs.gov/

SelfGovernance/. 

2. Questions on awards management 

and fiscal matters may be directed to: 

Indian Health Service, Division of 

Grants Management, 5600 Fishers Lane, 

Mail Stop: 09E70, Rockville, MD 20857, 

Email: DGM@ihs.gov. 

3. For technical assistance with 

Grants.gov, please contact the 

Grants.gov help desk at 800–518–4726, 

or by email at support@grants.gov. 

4. For technical assistance with 

GrantSolutions, please contact the 

GrantSolutions help desk at (866) 577– 

0771, or by email at help@

grantsolutions.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all grant, cooperative 

agreement, and contract recipients to 

provide a smoke-free workplace and 

promote the non-use of all tobacco 

products. In addition, Public Law 103– 

227, the Pro-Children Act of 1994, 

prohibits smoking in certain facilities 

(or in some cases, any portion of the 

facility) in which regular or routine 

education, library, day care, health care, 

or early childhood development 

services are provided to children. This 

is consistent with the HHS mission to 

protect and advance the physical and 

mental health of the American people. 

Roselyn Tso, 

Director, Indian Health Service. 

[FR Doc. 2023–26955 Filed 12–19–23; 8:45 am] 

BILLING CODE 4166–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

contract proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications 

and contract proposals, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–1: 

SBIR Contract Review. 

Date: February 1, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W102, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Shakeel Ahmad, Ph.D., 

Branch Chief, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W102, Rockville, Maryland 20850, 

240–276–6442, ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Projects in 

Physical Sciences Oncology Review. 

Date: February 2, 2024. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W640, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Rockville, 

Maryland 20850, 240–276–7684, 

saejeong.kim@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–5: NCI 

Clinical and Translational Cancer Research. 

Date: February 6–7, 2024. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W240, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Hasan Siddiqui, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W240, Rockville, 

Maryland 20850, 240–276–5122, 

hasan.siddiqui@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–5: 

SBIR Contract Review. 

Date: February 9, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W106, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Eduardo Emilio Chufan, 

Ph.D., Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W106, Rockville, Maryland 

20850, 240–276–7975, chufanee@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; The NCI 

Predoctoral to Postdoctoral Fellow Transition 

Award (F99/K00). 

Date: February 14–15, 2024. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 243 / Wednesday, December 20, 2023 / Notices 88101 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W238, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Byeong-Chel Lee, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W238, Rockville, Maryland 20850, 

240–276–7755, byeong-chel.lee@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI SPORE 

(P50) Review SEP–III. 

Date: February 15–16, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W244, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Amr M. Ghaleb, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W244, 

Rockville, Maryland 20850, 240–276–6611, 

amr.ghaleb@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–2: 

SBIR Contract Review. 

Date: February 15, 2024. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W238, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Jeffrey E. DeClue, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W238, Rockville, Maryland 

20850, 240–276–6371, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI R01/ 

R34 Advancing Adolescent Tobacco 

Cessation Intervention. 

Date: February 16, 2024. 

Time: 9:30 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W248, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Anita T. Tandle, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W248, 

Rockville, Maryland 20850, 240–276–5085, 

tandlea@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–7: NCI 

Clinical and Translational Cancer Research. 

Date: February 16, 2024. 

Time: 10:00 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W640, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Rockville, 

Maryland 20850, 240–276–7684, 

saejeong.kim@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Research Specialist Award (R50) Clinician. 

Date: February 22, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W242, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Zhiqiang Zou, M.D., Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W242, Rockville, 

Maryland 20850, 240–276–6372, zouzhiq@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–9: 

SBIR Contract Review. 

Date: February 28–29, 2024. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W106, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Eduardo Emilio Chufan, 

Ph.D., Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W106, Rockville, Maryland 

20850, 240–276–7975, chufanee@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–3: 

SBIR Contract Review. 

Date: February 29, 2024. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W238, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Jeffrey E. DeClue, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W238, Rockville, Maryland 

20850, 240–276–6371, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–4: 

SBIR Contract Review: Microbiome-Based 

Tests for Cancer Research. 

Date: February 29, 2024. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review, Branch Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W246, Rockville, Maryland 20850, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Research Specialist Award (R50). 

Date: February 29–March 1, 2024. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W242, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Zhiqiang Zou, M.D., Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W242, Rockville, 

Maryland 20850, 240–276–6372, zouzhiq@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI Assay 

Validation of High-Quality Markers for 

Clinical Studies in Cancer (UH2/3) meeting. 

Date: February 29, 2024 

Time: 12:30 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W244, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: John Paul Cairns, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W244, 

Rockville, Maryland 20850, 240–276–5415, 

paul.cairns@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–6: NCI 

Clinical and Translational Cancer Research. 

Date: March 1, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W260, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Robert F. Gahl, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9606 Medical 

Center Drive, Room 7W260, Rockville, 

Maryland 20850, 240–276–7869, robert.gahl@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–9: NCI 

Clinical and Translational Cancer Research. 

Date: March 6, 2024. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W526, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Viktoriya Sidorenko, 

Ph.D., Scientific Review Officer, Program and 

Review Extramural Staff Training Office, 


ddrumheller on DSK120RN23PROD with NOTICES1
88102 Federal Register / Vol. 88, No. 243 / Wednesday, December 20, 2023 / Notices 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W526, Rockville, Maryland 

20850, 240–276–5073, viktoriya.sidorenko@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Advanced 

Development of Informatics Technologies for 

Cancer Research. 

Date: March 6, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W246, Rockville, Maryland 20850, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–11: 

NCI Clinical and Translational Cancer 

Research. 

Date: March 7, 2024. 

Time: 10:00 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W238, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Byeong-Chel Lee, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W238, Rockville, Maryland 20850, 

240–276–7755, byeong-chel.lee@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Informatics Technologies for Cancer 

Research. 

Date: March 7, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W236, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Shuli Xia, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W236, Rockville, Maryland 20850, 

240–276–5256, shuli.xia@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Pediatric Early Phase Clinical Trial Network. 

Date: March 7, 2024. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W640, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Rockville, 

Maryland 20850, 240–276–7684, 

saejeong.kim@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Utilizing 

the PLCO Biospecimens Resource (U01). 

Date: March 21, 2024. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W120, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Majed M. Hamawy, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W120, 

Rockville, Maryland 20850, 240–276–6457, 

mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Mechanisms of Fusion-Driven Oncogenesis 

in Childhood Cancers and Next Generation 

Chemistry Centers for Fusion Oncoproteins. 

Date: March 29, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W260, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Robert F. Gahl, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9606 Medical 

Center Drive, Room 7W260, Rockville, 

Maryland 20850, 240–276–7869, robert.gahl@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 15, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–27963 Filed 12–19–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Innovations in Functional B 

Cell Epitope Discovery (N01). 

Date: January 18–19, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3F52, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Lindsey M. Pujanandez, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3F52, 

Rockville, MD 20852, (240) 627–3206, 

lindsey.pujanandez@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 14, 2023. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–27893 Filed 12–19–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 


ddrumheller on DSK120RN23PROD with NOTICES1